Rigel Pharmaceuticals
RIGL
RIGL
135 hedge funds and large institutions have $265M invested in Rigel Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 52 increasing their positions, 33 reducing their positions, and 8 closing their positions.
Holders
135
Holders Change
+9
Holders Change %
+7.14%
% of All Funds
2.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
52
Reduced
33
Closed
8
Calls
$44K
Puts
$49K
Net Calls
-$5K
Net Calls Change
-$2K
Top Buyers
| 1 |
1
BlackRock
New York
|
$31.5M |
| 2 |
2
Renaissance Technologies
New York
|
$10.6M |
| 3 |
TA
3
Tamarack Advisers
Carlsbad,
California
|
$12.5M |
| 4 |
4
Arrowstreet Capital
Boston,
Massachusetts
|
$2.02M |
| 5 |
JGC
5
J. Goldman & Co
New York
|
$1.88M |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$1.03M |
| 2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$23K |
| 3 |
3
Goldman Sachs
New York
|
$598K |
| 4 |
4
Morgan Stanley
New York
|
$2.49M |
| 5 |
SI
5
Sofinnova Investments
Menlo Park,
California
|
$622K |
